The Effect of Ketamine Infusion on Lumbar Surgery
Brief Summary
The purpose of this study is to evaluate the effect of ketamine infusion for reduction of neuropathic pain and improvement of quality of life after lumbar surgery.
Study Design
| Study type: | Interventional |
|---|---|
| Status: | Unknown status |
| Study results: | No Results Available |
| Age: | 20 Years to 70 Years (Adult, Older Adult) |
| Enrollment: | 56 () |
| Funded by: | Other |
Masking |
|
Clinical Trial Dates
| Start date: | May 14, 2022 | |
|---|---|---|
| Primary Completion: | Apr 15, 2022 | |
| Completion Date: | Apr 15, 2022 | |
| Study First Posted: | Jun 03, 2014 | |
| Results First Posted: | Aug 31, 2020 | |
| Last Updated: | Jun 03, 2014 |
Sponsors / Collaborators
Lead Sponsor:
N/A
Responsible Party:
N/A
Location
Neuropathic pain defined as 'pain caused by a lesion or disease of the somatosensory system'. Neuropathic pain is 20 - 35% of low back pain.
Ketamine is categorized as N-methyl D-aspartate receptor antagonist. Ketamine has an analgesic effect in low dose and anesthetic effect in relative high dose. Also, ketamine is used in chronic neuropathic pain as postherpetic neuralgia., phantom pain, central neuropathic pain, complex regional pain syndrome, ischemic pain.
In this study, ketamine will be infused during lumbar surgery in randomized, double-blind and double-blind parallel group control trial.
Eligibility Criteria
| Sex: | All |
|---|---|
| Minimum Age: | 20 |
| Maximum Age: | 70 |
More Details
| NCT Number: | NCT02154438 |
|---|---|
| Other IDs: | 3-2014-0062 |
| Study URL: | https://ClinicalTrials.gov/show/NCT02154438 |
Last updated: Jun 17, 2022